Back

Prevalence and impact of a pathogenic CYP27A1 variant on phenotypes among patients with monogenic heterozygous familial hypercholesterolemia

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and coronary artery disease (1) Lipids ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

5 More presentations in this session

Presentation thumbnail
Apolipoprotein b discordance at very low low-density lipoprotein cholesterol thresholds: a patient-level analysis
Doctor J. Bernhard (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Nationwide genotypic and phenotypic characterisation of homozygous familial hypercholesterolemia
Doctor C. Lin (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Clinical impact of more than 50% reduction in low-density lipoprotein cholesterol at 6 weeks after percutaneous coronary intervention for acute coronary syndrome
Doctor K. Murai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence of elevated lipoprotein(a) [Lp(a)] in patients with familial hypercholesterolemia (FH)
Doctor J. Sawhney (New Delhi, IN)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) lowering and risk of cardiovascular disease in primary and secondary prevention
Mr P. Kamstrup (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and coronary artery disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Coronary computed tomography and cardiovascular outcomes in genetically confirmed familial hypercholesterolemia
29 August 2026
thumbnail
Congress Presentation
Prevalence and disease expression of pathogenic and likely pathogenic variants associated with ARVC in a large cohort
30 August 2026
thumbnail
Congress Presentation
Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
31 August 2024
thumbnail
Congress Presentation
Clinical characteristics and outcomes of danon disease in women: a single center experience
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources